From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: So this is how I am making cash from the green shite Malcolm yaks on about

By Tom Winnifrith | Saturday 24 April 2021


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Tomorrow sees a 23 mile training walk. It is nothing to do with the fact that the mother-in-law has just arrived but a recognition that Rogue Bloggers for Woodlarks and that 34 miles is now just 5 weeks away. Think of the pain tomorrow and please donate HERE – we are now at just under £14,000 so please do give what you can afford.  In the podcast, I look at the green madness of Malcolm Stacey, Boris Johnson and creepy Joe Biden and why I do not believe in any of it and how I shall make money from it.  Then I discuss the scam, I exposed today, of claiming that a dual OTC listing will push share prices higher: it will not!

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:41:38